根治性前列腺切除术后伴与不伴同步淋巴结转移的ISUP分级分组2前列腺癌中筛状结构与导管内癌的预后价值:一项病例对照匹配的多中心研究结果
该多中心病例对照匹配研究纳入1060例根治性前列腺切除术后ISUP分级分组2前列腺癌患者,其中79例(7.4%)为pN1。匹配后106例(53例pN1与53例pN0)分析显示,CR/IDC在pN1标本中显著更常见(100% vs 51%,P<.001);pN0患者中CR/IDC阳性与BCRFS(HR=0.90,95% CI 0.32-2.55,P=.842)和RRFS(HR 2.45,95% CI 0.45-13.34,P=.299)无显著关联;pN1且CR/IDC阳性者与不良BCRFS(HR=2.93,95% CI 1.26-6.83,P=.013)和RRFS(HR=9.19,95% CI 2.11-40.04,P=.003)相关。
要点
- ISUP GG2前列腺癌中CR/IDC与同步淋巴结转移强相关(pN1 100% vs pN0 51%,P<.001)。
- pN0患者中CR/IDC阳性与BCRFS及RRFS无显著关联。
- pN1且CR/IDC阳性与不良BCRFS和RRFS相关。
核心结论
- 在ISUP GG2前列腺癌中,CR/IDC与同步淋巴结转移强相关,而淋巴结转移与不良结局相关。
研究设计与样本
- 多中心、国际队列研究,纳入3家三级转诊中心接受根治性前列腺切除加盆腔淋巴结清扫的1060例ISUP GG2前列腺癌患者,其中79例(7.4%)为pN1。
- 采用病例对照匹配,匹配变量为初始前列腺特异性抗原(iPSA)值、pT分期、年龄、手术切缘状态和转诊中心,比较pN1与pN0患者的组织病理学特征和肿瘤学结局。
- 匹配后纳入106例患者(即53例病例和53例对照)。
- 采用Cox回归分析评估CR/IDC对生化复发无生存(BCRFS,定义为RP至PSA≥0.2ng/mL的间隔)和影像学复发无生存(RRFS,定义为RP至影像学复发的间隔)的预测价值。
主要发现
- CR/IDC在pN1根治性前列腺切除标本中显著比pN0更常见(100% vs 51%,P<.001)。
- 在pN0患者中,CR/IDC阳性与BCRFS无关联(HR=0.90,95% CI 0.32-2.55,P=.842),与RRFS也无关联(HR 2.45,95% CI 0.45-13.34,P=.299)。
- 在多变量Cox回归分析中,pN1且CR/IDC阳性的前列腺癌与不良BCRFS相关(HR=2.93,95% CI 1.26-6.83,P=.013),与不良RRFS也相关(HR=9.19,95% CI 2.11-40.04,P=.003)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the occurrence and the oncological predictive value of cribriform growth and/or intraductal carcinoma (CR/IDC) in patients with ISUP grade group (GG) 2 prostate cancer (PCa) at radical prostatectomy (RP) with and without synchronous nodal metastases in a multicenter, international cohort. METHODS: We identified 1060 patients who underwent RP with ISUP GG2 PCa at histopathology and a pelvic lymph node dissection from 3 tertiary referral centers. Of these, 79 (7.4%) had pN1 disease. Case-control matching was performed using the initial prostate-specific antigen (iPSA) value, pT-stage, age, surgical margin status, and referral center as matching variables to compare histopathological characteristics and oncological outcomes between pN1 and pN0 patients. The predictive value of CR/IDC for biochemical recurrence-free survival (BCRFS), defined as the interval between RP and a PSA of ≥0.2ng/mL, and radiological recurrence-free survival (RRFS), defined as the interval between RP and an RR, was evaluated using Cox regression analysis. RESULTS: After case-control matching, 106 patients were included (ie, 53 cases and 53 controls). CR/IDC was significantly more common in pN1 than pN0 RP specimens (100% vs 51%, P<.001). In pN0 patients, CR/IDC positivity was not associated with BCRFS (hazard ratio [HR]=0.90, 95% CI 0.32-2.55, P=.842) or RRFS (HR 2.45, 95% CI 0.45-13.34, P=.299). pN1 CR/IDC-positive PCa was associated with adverse BCRFS (HR=2.93, 95% CI 1.26-6.83, P=.013) and RRFS (HR=9.19, 95% CI 2.11-40.04, P=.003) in multivariable Cox regression analysis. CONCLUSION: In ISUP GG2 PCa, CR/IDC strongly correlates with synchronous nodal metastases, the latter being associated with adverse outcomes.
引用
- de Barros HA, Downes MR, Droghetti M, et al. Prognostic Value of Cribriform and Intraductal Carcinoma in Grade Group 2 Prostate Cancer With and Without Synchronous Nodal Metastases at Radical Prostatectomy: Results From a Case-control Matched, Multicenter Study. Urology. 2025. PMID: 39922236. doi:10.1016/j.urology.2025.01.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。